B

Binex Co Ltd
KOSDAQ:053030

Watchlist Manager
Binex Co Ltd
KOSDAQ:053030
Watchlist
Price: 17 660 KRW -2.21% Market Closed
Market Cap: 562.4B KRW
Have any thoughts about
Binex Co Ltd?
Write Note

Binex Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Binex Co Ltd
Cost of Revenue Peer Comparison

Comparables:
000100
326030
128940
S
000250
C
068760

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
B
Binex Co Ltd
KOSDAQ:053030
Cost of Revenue
-â‚©101.8B
CAGR 3-Years
-14%
CAGR 5-Years
-10%
CAGR 10-Years
-12%
Yuhan Corp
KRX:000100
Cost of Revenue
-â‚©1.3T
CAGR 3-Years
2%
CAGR 5-Years
-4%
CAGR 10-Years
-7%
SK Biopharmaceuticals Co Ltd
KRX:326030
Cost of Revenue
-â‚©34.1B
CAGR 3-Years
-158%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Cost of Revenue
-â‚©693.6B
CAGR 3-Years
-10%
CAGR 5-Years
-7%
CAGR 10-Years
-8%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Cost of Revenue
-â‚©105B
CAGR 3-Years
-11%
CAGR 5-Years
-7%
CAGR 10-Years
-8%
C
Celltrion Pharm Inc
KOSDAQ:068760
Cost of Revenue
-â‚©293.1B
CAGR 3-Years
-8%
CAGR 5-Years
-20%
CAGR 10-Years
-31%

See Also

What is Binex Co Ltd's Cost of Revenue?
Cost of Revenue
-101.8B KRW

Based on the financial report for Jun 30, 2024, Binex Co Ltd's Cost of Revenue amounts to -101.8B KRW.

What is Binex Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-12%

Over the last year, the Cost of Revenue growth was -7%. The average annual Cost of Revenue growth rates for Binex Co Ltd have been -14% over the past three years , -10% over the past five years , and -12% over the past ten years .

Back to Top